Regional Fish Institute Ltd. in Japan is now accepting orders on a crowdfunding site for genetically manipulated farmed red sea bream that boasts 1.2 times thicker flesh than ordinary farmed ones.
Sales are initially restricted to 190 customers with deliveries expected to start in October. The production process is explained in detail with each purchase.
Kyoto University and Kindai University developed the fleshier fish variant by rendering a gene called myostatin that controls muscle growth.
The Regional Fish Institute, a biotech enterprise affiliated with Kyoto University, registered the commercialization of its “genome-edited food” with the government on Sept. 17.
On the same day, the health ministry declared that no safety examinations were required.
Genome editing, which aims to destroy or introduce particular genes, is also applied for increasing harvest yields in rice and other plant varieties.
As no foreign genes from other species were introduced into genome-processed items, as with genetic recombination, no safety checks were necessary.
This method is essentially the same as traditional selective breeding methods to create improved varieties.
The institute's sea bream is the first genome-edited animal product to be marketed in Japan.


Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Asian Currencies Stay Rangebound as Yen Firms on Intervention Talk
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 



